Sanchez, Christelle ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.)
Walsh, David
Delcour, Jean-Pierre
Baudouin, Caroline
Msika, Philippe
Henrotin, Yves ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.)
Language :
English
Title :
Bone sialoprotein as a potential key factor implicated in the pathophysiology of osteoarthritis
van der Kraan P.M., van den Berg W.B. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration?. Osteoarthritis Cartilage 2012, 20:223-232.
Ea H.K., Nguyen C., Bazin D., Bianchi A., Guicheux J., Reboul P., et al. Articular cartilage calcification in osteoarthritis: insights into crystal-induced stress. Arthritis Rheum 2011, 63:10-18.
Tchetina E.V. Developmental mechanisms in articular cartilage degradation in osteoarthritis. Arthritis 2011, 2011:683970.
Gelse K., Soder S., Eger W., Diemtar T., Aigner T. Osteophyte development - molecular characterization of differentiation stages. Osteoarthritis Cartilage 2003, 11:141-148.
Nagase H., Kashiwagi M. Aggrecanases and cartilage matrix degradation. Arthritis Res Ther 2003, 5:94-103.
Clark J.M. The structure of vascular channels in the subchondral plate. JAnat 1990, 171:105-115.
Bonde H.V., Talman M.L., Kofoed H. The area of the tidemark in osteoarthritis - a three-dimensional stereological study in 21 patients. APMIS 2005, 113:349-352.
Walsh D.A., Bonnet C.S., Turner E.L., Wilson D., Situ M., McWilliams D.F. Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthritis Cartilage 2007, 15:743-751.
Suri S., Gill S.E., Massena de Camin S., Wilson D., McWilliams D.F., Walsh D.A. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann Rheum Dis 2007, 66:1423-1428.
von der Mark K., Kirsch T., Nerlich A., Kuss A., Weseloh G., Gluckert K., et al. Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum 1992, 35:806-811.
Aigner T., Reichenberger E., Bertling W., Kirsch T., Stoss H., von der Mark K. Type X collagen expression in osteoarthritic and rheumatoid articular cartilage. Virchows Arch B Cell Pathol Incl Mol Pathol 1993, 63:205-211.
von der Mark K., Frischholz S., Aigner T., Beier F., Belke J., Erdmann S., et al. Upregulation of type X collagen expression in osteoarthritic cartilage. Acta Orthop Scand Suppl 1995, 266:125-129.
Solomon L.A., Berube N.G., Beier F. Transcriptional regulators of chondrocyte hypertrophy. Birth Defects Res C Embryo Today 2008, 84:123-130.
Kamekura S., Kawasaki Y., Hoshi K., Shimoaka T., Chikuda H., Maruyama Z., et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum 2006, 54:2462-2470.
Nurminskaya M., Linsenmayer T.F. Identification and characterization of up-regulated genes during chondrocyte hypertrophy. Dev Dyn 1996, 206:260-271.
Alvarez J., Balbin M., Santos F., Fernandez M., Ferrando S., Lopez J.M. Different bone growth rates are associated with changes in the expression pattern of types II and X collagens and collagenase 3 in proximal growth plates of the rat tibia. JBone Miner Res 2000, 15:82-94.
Shlopov B.V., Gumanovskaya M.L., Hasty K.A. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis. Arthritis Rheum 2000, 43:195-205.
Dreier R. Hypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disorders. Arthritis Res Ther 2010, 12:216.
Pesesse L., Sanchez C., Delcour J.-P., Bellahcène A., Baudouin C., Msika P., et al. Consequences of chondrocyte hypertrophy on osteoarthritic cartilage, potential effect on angiogenesis. Osteoarthritis Cartilage 2013, 21:1913-1923.
Fisher L.W., McBride O.W., Termine J.D., Young M.F. Human bone sialoprotein. Deduced protein sequence and chromosomal localization. JBiol Chem 1990, 265:2347-2351.
Bianco P., Fisher L.W., Young M.F., Termine J.D., Robey P.G. Expression of bone sialoprotein (BSP) in developing human tissues. Calcif Tissue Int 1991, 49:421-426.
Gordon J.A., Tye C.E., Sampaio A.V., Underhill T.M., Hunter G.K., Goldberg H.A. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization invitro. Bone 2007, 41:462-473.
Malaval L., Aubin J.E., Vico L. Role of the small integrin-binding ligand N-linked glycoprotein (SIBLING), bone sialoprotein (BSP) in bone development and remodeling. Osteoporos Int 2009, 20:1077-1080.
Hunter G.K., Goldberg H.A. Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci U S A 1993, 90:8562-8565.
Wollheim F.A. Bone sialoprotein-a new marker for subchondral bone. Osteoarthritis Cartilage 1999, 7:331-332.
Stubbs J.T., Mintz K.P., Eanes E.D., Torchia D.A., Fisher L.W. Characterization of native and recombinant bone sialoprotein: delineation of the mineral-binding and cell adhesion domains and structural analysis of the RGD domain. JBone Miner Res 1997, 12:1210-1222.
Byzova T.V., Kim W., Midura R.J., Plow E.F. Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein. Exp Cell Res 2000, 254:299-308.
Bellahcene A., Bonjean K., Fohr B., Fedarko N.S., Robey F.A., Young M.F., et al. Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res 2000, 86:885-891.
Sanchez C., Deberg M.A., Piccardi N., Msika P., Reginster J.Y., Henrotin Y.E. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1beta and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis Cartilage 2005, 13:979-987.
Saxne T., Di Giovine F.S., Heinegard D., Duff G.W., Wollheim F.A. Synovial fluid concentrations of interleukin-1 beta and proteoglycans are inversely related. JAutoimmun 1988, 1:373-380.
Saxne T., Palladino M.A., Heinegard D., Talal N., Wollheim F.A. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988, 31:1041-1045.
Collins D.H. Osteoarthritis. The Pathology of Articular and Spinal Diseases 1949, 74-115. London. E. Arnold (Ed.).
Lamour V., Detry C., Sanchez C., Henrotin Y., Castronovo V., Bellahcene A. Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression. JBiol Chem 2007, 282:36240-36249.
Walsh D.A., Yousef A., McWilliams D.F., Hill R., Hargin E., Wilson D. Evaluation of a Photographic Chondropathy Score (PCS) for pathological samples in a study of inflammation in tibiofemoral osteoarthritis. Osteoarthritis Cartilage 2009, 17:304-312.
Mankin H.J., Lippiello L. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. JBone Joint Surg Am 1970, 52:424-434.
Labarca C., Paigen K. Asimple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980, 102:344-352.
Jiang J., Leong N.L., Mung J.C., Hidaka C., Lu H.H. Interaction between zonal populations of articular chondrocytes suppresses chondrocyte mineralization and this process is mediated by PTHrP. Osteoarthritis Cartilage 2008, 16:70-82.
Kozhemyakina E., Cohen T., Yao T.P., Lassar A.B. Parathyroid hormone-related peptide represses chondrocyte hypertrophy through a protein phosphatase 2A/histone deacetylase 4/MEF2 pathway. Mol Cell Biol 2009, 29:5751-5762.
Fischer J., Dickhut A., Rickert M., Richter W. Human articular chondrocytes secrete parathyroid hormone-related protein and inhibit hypertrophy of mesenchymal stem cells in coculture during chondrogenesis. Arthritis Rheum 2010, 62:2696-2706.
Heldens G.T., Blaney Davidson E.N., Vitters E.L., Schreurs B.W., Piek E., van den Berg W.B., et al. Catabolic factors and osteoarthritis-conditioned medium inhibit chondrogenesis of human mesenchymal stem cells. Tissue Eng Part A 2012, 18:45-54.
Simsa-Maziel S., Monsonego-Ornan E. Interleukin-1beta promotes proliferation and inhibits differentiation of chondrocytes through a mechanism involving down-regulation of FGFR-3 and p21. Endocrinology 2012, 153:2296-2310.
Conrozier T., Saxne T., Fan C.S., Mathieu P., Tron A.M., Heinegard D., et al. Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study. Ann Rheum Dis 1998, 57:527-532.
Petersson I.F., Boegard T., Svensson B., Heinegard D., Saxne T. Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol 1998, 37:46-50.
Lohmander L.S., Saxne T., Heinegard D. Increased concentrations of bone sialoprotein in joint fluid after knee injury. Ann Rheum Dis 1996, 55:622-626.
Lawler P.R., Lawler J. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harb Perspect Med 2012, 2:a006627.
Huang S., Mills L., Mian B., Tellez C., McCarty M., Yang X.D., et al. Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol 2002, 161:125-134.
Martin D., Galisteo R., Gutkind J.S. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. JBiol Chem 2009, 284:6038-6042.
Ning Y., Manegold P.C., Hong Y.K., Zhang W., Pohl A., Lurje G., et al. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity invitro and invivo in colon cancer cell line models. Int J Cancer 2011, 128:2038-2049.
de Bri E., Lei W., Reinholt F.P., Mengarelli-Widholm S., Heingard D., Svensson O. Ultrastructural immunolocalization of bone sialoprotein in guinea-pig osteoarthritis. Osteoarthritis Cartilage 1997, 5:387-393.
Shen Z., Heinegard D., Sommarin Y. Distribution and expression of cartilage oligomeric matrix protein and bone sialoprotein show marked changes during rat femoral head development. Matrix Biol 1995, 14:773-781.
Oldberg A., Franzen A., Heinegard D. The primary structure of a cell-binding bone sialoprotein. JBiol Chem 1988, 263:19430-19432.
